| Volume 19 • Issue 8 |
April 17, 2019 |
|
|
|
|
 |
| |
SOFRACORT® RETURNS TO MARKET
|
|
|
Sanofi-aventis Canada Inc. is pleased to announce the return of SOFRACORT® to the Canadian market.
READ MORE
|
 |
|
|
| |
PRALUENT® WILL EXPERIENCE A BRIEF INVENTORY SHORTAGE
|
|
|
Sanofi-aventis Canada Inc. would like to inform you that the solution for subcutaneous injection Praluent® (Alirocumab) 75mg/mL & 150mg/mL will experience a brief shortage due to a supply delay (estimated depletion date of April 15th and May 6th respectively). The estimated date of return to inventory is scheduled for May 6th and May 13th respectively.
READ MORE
|
 |
|
|
| |
TEMPORARY SHORTAGE OF NALCROM®
|
|
|
Sanofi-aventis Canada Inc would like to inform you that Nalcrom® is on temporary shortage.
READ MORE
|
|
|
|
 |
| |
PrEUCRISATM - NOW AVAILABLE TO ORDER
|
|
|
Pfizer Canada is pleased to announce the launch and availability of PrEUCRISATM (crisaborole ointment 2%). EUCRISA is available in 60 gram tubes. To access EUCRISA Patient Information,
CLICK HERE
|
 |
|
|
|
|
| |
TEAR-GEL® – FOR DRY EYE RELIEF
|
|
|
Tear-Gel® is a highly viscous clear gel to treat mild to severe dry eyes. It forms a protective film with a long corneal contact time and provides long-lasting relief without blurring.
READ MORE
|
 |
|
| |
IMMUNE HEALTH IS A DAILY COMMITMENT.
|
|
|
Our body has the natural capacity to defend itself, but sometimes it needs our help. COLD-FX® Daily Support has a clinically proven formula to help reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system.
READ MORE
|
 |
|
|
|
|
